Survival in women diagnosed with breast and cervical cancer in Poland – compared to European countries, based on CONCORD - 3 Programme

Abstract

INTRODUCTION. The 5-year population-based survival rate, next to cancer incidence and mortality, is a key element for the assessment of effective health care quality provided by OECD in order to establish the condition of health care and set up health care policies. They also apply when assessing breast and cervical cancer prevention in Poland. AIM. The aim of the paper was to analyse the breast and cervical cancer survival in women in Poland in 2010-2014 and its changes in 2000-2014 in comparison to other European countries. RESULTS. The analysis of the 5-year survival rate was performed with the CONCORD-3 programme data. In order to guarantee the comparability of results, the uniform standards for data quality control, all calculations and analyses were performed by a world-leading centre for research, The London School of Hygiene and Tropical Medicine. The absolute value of the survival rate was used to assess survival variations in 2000-2004 and 2010-2014. In 2010-2014 the highest 5-year survival rate in women with breast cancer was in Island (89%), Sweden (89%), Finland (89%) and Norway (88%). Despite its systematic improvement, the 5-year survival rate in Poland was lower than in the majority of European countries, and in the final period amounted to 76,6%. In 2010-2014 the highest survival in women with cervical cancer in Europe was in Island (80%), Norway (73%) and Switzerland (71%). The progress of favourable changes in Poland was not sufficient enough to allow the survival rate (55%) to be significantly closer to the European average. CONCLUSIONS. The 5-year survival rate for breast and cervical cancer in Poland in 2010-2014 was significantly different than in other European countries, and placed Poland among the countries with the lowest survival rate. In 2000-2014 in Poland there was an insignificant progress in survival in women with breast and cervical cancer, which did not contribute to fighting the substantial differences when compared to other European countries.

Epidemiology of women diagnosed with breast cancer in Jordan

“…The 5-year OS in Canada was 88%, the United States was 91%, European countries were 73.5-89.1%, and Australia (2012-2016) was 91%. 23,[28][29][30][31] Variation in survival rates amongst countries reflects the variation in the introduction of national detection programs and the early BC screening. Particularly, the detection of BC in early stages is associated with less aggressive treatment and better OS in addition to different life spans for the registry data available.…”

Survival of Cervical Cancer Patients in Brunei Darussalam: 2002-2017

“…Our study shows that the overall national 5-year survival rate in Brunei is 74.1% from 2002-2017. This indicates that survival of cervical cancer patients in Brunei is at par with survival in high-resource nations (in 2010-2014, the highest 5-year survival in women with cervical cancer in Europe was in Iceland (80%), Norway (73%) and Switzerland (71%) [8] ). Meanwhile, the highest 5-year survival rates among Organisation for Economic Co-operation and Development (OECD) countries have previously been reported in Korea (76.8%), Norway (71.4%) and Israel (71.4%), with the average from 19 OECD countries (OECD19) at 66% for the period 2006-2011 [9] .…”

Selected dietary factors and breast cancer risk

“…Liczby w Europie wskazują, że bezwzględna liczba nowych przypadków i zgonów z powodu tej choroby nadal rośnie (2). Sytuacja ta dotyczy również Polski, gdzie dodatkowo przeżywalność jest istotnie niższa niż w innych krajach europejskich (5).…”

“…The incidence rate of breast cancer ranges from 19.4 per 100,000 people in East Africa to 89.7 per 100,000 in West Europe (4). Figures in Europe indicate that the absolute number of new diagnosis and deaths due to this disease continues to increase (5). This situation also applies to Poland, where the survival rate is significantly lower than in other European countries (5).…”